Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments, and Licenses - Schedule of Consolidated Assets and Non-Recourse Liabilities (Details)

v3.3.0.814
Acquisitions, Investments, and Licenses - Schedule of Consolidated Assets and Non-Recourse Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Sep. 30, 2014
Dec. 31, 2013
Current assets:        
Cash and cash equivalents $ 212,144 $ 96,907 [1] $ 118,258 $ 185,798
Accounts receivable, net 189,725 19,969 [1]    
Inventory, net 40,693 16,604 [1]    
Prepaid expenses and other current assets 74,854 9,389 [1]    
Total current assets 517,416 142,869 [1]    
Property, plant and equipment, net 126,822 16,411 [1]    
Intangible assets, net 660,287 62,649 [1]    
Goodwill 761,234 224,292 [1]    
Other assets, principally deferred tax assets 102,676 5,838 [1]    
Total assets 3,015,853 1,267,664 [1]    
Current liabilities:        
Accounts payable 77,969 8,744 [1]    
Accrued expenses 201,113 60,912 [1]    
Total current liabilities 357,590 83,111 [1]    
Other long-term liabilities 236,476 50,205    
Total liabilities $ 1,046,485 431,923 [1]    
SciVac | Variable Interest Entity, Primary Beneficiary        
Current assets:        
Cash and cash equivalents   393    
Accounts receivable, net   316    
Inventory, net   1,649    
Prepaid expenses and other current assets   718    
Total current assets   3,076    
Property, plant and equipment, net   1,725    
Intangible assets, net   875    
Goodwill   1,553    
Other assets, principally deferred tax assets   384    
Total assets   7,613    
Current liabilities:        
Accounts payable   445    
Accrued expenses   4,446    
Notes payable   5,189    
Total current liabilities   10,080    
Other long-term liabilities   2,042    
Total liabilities   $ 12,122    
[1] As of December 31, 2014, total assets include $7.6 million and total liabilities include $12.1 million related to SciVac Ltd (“SciVac”). SciVac was a consolidated variable interest entity which we deconsolidated in July 2015. Refer to Note 5. SciVac’s consolidated assets were owned by SciVac and SciVac’s consolidated liabilities had no recourse against us.